XNAS: TRVI
Trevi Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary f...
Read More
18.40
-0.19
(-1.02%)
1.5M
XNAS Volume
XNAS 09 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Trevi Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..